Dana Aftab T.'s Insider Trades & SAST Disclosures
Dana Aftab T.'s most recent trade in Exelixis Inc was a trade of 49,209 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dana Aftab T..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 49,209 | 561,117 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Sale of securities on an exchange or to another person at price $ 36.75 per share. | 24 Feb 2025 | 26,987 | 511,908 (0%) | 0% | 36.7 | 991,772 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.00 per share. | 15 Feb 2025 | 16,053 | 551,590 (0%) | 0% | 35 | 561,855 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.00 per share. | 15 Feb 2025 | 12,695 | 538,895 (0%) | 0% | 35 | 444,325 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 104,106 | 590,213 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.27 per share. | 16 Jan 2025 | 22,570 | 567,643 (0%) | 0% | 37.3 | 841,184 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.05 per share. | 15 Nov 2024 | 12,838 | 486,107 (0%) | 0% | 35.1 | 449,972 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 05 Nov 2024 | 96,986 | 498,945 (0%) | 0% | 35 | 3,394,510 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 96,986 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.80 per share. | 05 Nov 2024 | 96,986 | 595,931 (0%) | 0% | 18.8 | 1,823,337 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Sale of securities on an exchange or to another person at price $ 31.40 per share. | 30 Oct 2024 | 1,162 | 498,945 (0%) | 0% | 31.4 | 36,487 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Sale of securities on an exchange or to another person at price $ 27.06 per share. | 12 Aug 2024 | 20,883 | 500,107 (0%) | 0% | 27.1 | 565,094 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.41 per share. | 07 Aug 2024 | 95,000 | 615,990 (0%) | 0% | 24.4 | 2,318,950 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2024 | 95,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 07 Aug 2024 | 95,000 | 520,990 (0%) | 0% | 25 | 2,375,000 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 15 May 2024 | 8,658 | 520,990 (0%) | 0% | 21.0 | 181,731 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 15 May 2024 | 7,538 | 529,648 (0%) | 0% | 21.0 | 158,223 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 15 May 2024 | 6,409 | 537,186 (0%) | 0% | 21.0 | 134,525 | Common Stock |
| Exelixis Inc | Dana Aftab T. | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 63,350 | 542,381 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Aftab T. Dana | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.39 per share. | 15 Feb 2024 | 10,630 | 479,031 (0%) | 0% | 20.4 | 216,746 | Common Stock |
| Exelixis Inc | T. Aftab Dana | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 63,224 | 501,267 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dana Aftab T. | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.86 per share. | 11 Jan 2024 | 11,606 | 489,661 (0%) | 0% | 22.9 | 265,313 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.51 per share. | 15 Aug 2023 | 6,280 | 404,543 (0%) | 0% | 21.5 | 135,083 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 15 May 2023 | 6,115 | 410,823 (0%) | 0% | 19.2 | 117,286 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 15 May 2023 | 4,373 | 416,938 (0%) | 0% | 19.2 | 83,874 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 68,331 | 419,803 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 82,490 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 27 Feb 2023 | 82,490 | 351,472 (0%) | 0% | 17.5 | 1,443,575 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.74 per share. | 27 Feb 2023 | 82,490 | 433,962 (0%) | 0% | 14.7 | 1,215,903 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.70 per share. | 27 Feb 2023 | 10 | 351,482 (0%) | 0% | 14.7 | 147 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 10 | 82,490 | - | - | Option (right to buy) | |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 27 Feb 2023 | 10 | 351,472 (0%) | 0% | 17.5 | 175 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.08 per share. | 15 Feb 2023 | 1,529 | 351,472 (0%) | 0% | 18.1 | 27,644 | Common Stock |
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 100,000 | 353,001 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges